Reduction in Opioid-Related Adverse Events and Improvement in Function with Parecoxib followed by Valdecoxib Treatment after Non-Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial

Author： Langford Richard M.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.29, Iss.9, 2009-09, pp. : 577-590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Capsaicin Instillation for Postoperative Pain following Total Knee Arthroplasty: A Preliminary Report of a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicentre Trial

By Hartrick Craig T.   Pestano Cecile   Carlson Nickole   Hartrick Susan  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 877-882

Adis International

Access to resources Recommend Favorite

Efficacy of a Non-Hormonal Treatment, BRN-01, on Menopausal Hot Flashes: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

By Colau Jean-Claude  

Drugs in R&D, Vol. 12, Iss. 3, 2012-09 ,pp. : 107-119

Adis International

Access to resources Recommend Favorite

Diclofenac Epolamine plus Heparin Plaster versus Diclofenac Epolamine Plaster in Mild to Moderate Ankle Sprain: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicentre, Phase III Trial

By Costantino Cosimo  

Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. : 15-26

Adis International

Access to resources Recommend Favorite

Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study

By Walfridsson Håkan  

Clinical Drug Investigation, Vol. 30, Iss. 7, 2010-07 ,pp. : 461-471

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study with an Open-Label Extension

By Na Yanqun  

Clinical Drug Investigation, Vol. 32, Iss. 1, 2012-01 ,pp. : 29-39

Adis International

Access to resources Recommend Favorite